Kenzo Tokunaga

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

Inhibition of placental trophoblast fusion by guanylate-binding protein 5.

Inhibition of placental trophoblast fusion by guanylate-binding protein 5.

Journal: Science advances
Published: May 07, 2025

HIV-1 and BLV are insensitive to SERINC5 restriction under the cell-cell infection.

HIV-1 and BLV are insensitive to SERINC5 restriction under the cell-cell infection.

Journal: Microbiology spectrum
Published: January 27, 2025

Prolonged effects of adenoviral vector priming on T-cell cytokine production in heterologous adenoviral vector/mRNA COVID-19 vaccination regimens.

Prolonged effects of adenoviral vector priming on T-cell cytokine production in heterologous adenoviral vector/mRNA COVID-19 vaccination regimens.

Journal: Scientific reports
Published: December 05, 2024

Further Characterization of the Antiviral Transmembrane Protein MARCH8.

Further Characterization of the Antiviral Transmembrane Protein MARCH8.

Journal: Cells
Published: March 08, 2024

Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.

Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 22, 2023

Membrane-Associated Ubiquitin Ligase RING Finger Protein 152 Orchestrates Melanogenesis via Tyrosinase Ubiquitination.

Membrane-Associated Ubiquitin Ligase RING Finger Protein 152 Orchestrates Melanogenesis via Tyrosinase Ubiquitination.

Journal: Membranes
Published: November 28, 2023

Determination of the factors responsible for the tropism of SARS-CoV-2-related bat coronaviruses to Rhinolophus bat ACE2.

Determination of the factors responsible for the tropism of SARS-CoV-2-related bat coronaviruses to Rhinolophus bat ACE2.

Journal: Journal of virology
Published: September 19, 2023

Repetitive mRNA vaccination is required to improve the quality of broad-spectrum anti-SARS-CoV-2 antibodies in the absence of CXCL13.

Repetitive mRNA vaccination is required to improve the quality of broad-spectrum anti-SARS-CoV-2 antibodies in the absence of CXCL13.

Journal: Science advances
Published: August 04, 2023

Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon.

Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon.

Journal: PloS one
Published: March 25, 2022

MARCH8 Targets Cytoplasmic Lysine Residues of Various Viral Envelope Glycoproteins.

MARCH8 Targets Cytoplasmic Lysine Residues of Various Viral Envelope Glycoproteins.

Journal: Microbiology spectrum
Published: January 12, 2022

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants.

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants.

Journal: Med (New York, N.Y.)
Published: December 29, 2021

The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance.

The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance.

Journal: Cell reports
Published: August 30, 2021
Showing 1-12 of 40

Last Updated: 09/26/2026